Rural Health
Resources by Topic: Pharmacy and prescription drugs
Disadvantaged Groups Have Greater Spatial Access to Pharmacies in New York State
Examines spatial pharmacy access in low-income and racial minority communities across New York State. Utilizes population weighted mean shortest road network distance (PWMSD) to examine distance to closest pharmacy. Includes Census Tract-level maps showing demographics such as poverty, education level, Black, and Hispanic/Latino quartile percentages and the correlation to pharmacy access. Includes discussion about how rurality factors into pharmacy access for disadvantaged groups.
Author(s): Abhinav Suri, James Quinn, Raymond R. Balise, et al.
Citation: BMC Health Services Research, 24, 471
Date: 04/2024
Type: Document
view details
Examines spatial pharmacy access in low-income and racial minority communities across New York State. Utilizes population weighted mean shortest road network distance (PWMSD) to examine distance to closest pharmacy. Includes Census Tract-level maps showing demographics such as poverty, education level, Black, and Hispanic/Latino quartile percentages and the correlation to pharmacy access. Includes discussion about how rurality factors into pharmacy access for disadvantaged groups.
Author(s): Abhinav Suri, James Quinn, Raymond R. Balise, et al.
Citation: BMC Health Services Research, 24, 471
Date: 04/2024
Type: Document
view details
Locations and Characteristics of Pharmacy Deserts in the United States: A Geospatial Study
Classifies census tracts as pharmacy deserts or non-pharmacy deserts. Compares pharmacy desert and non-pharmacy desert areas by various social determinants of health and pharmacy characteristics including rurality. See the supplemental materials for state-by-state and rural/urban comparisons.
Author(s): Rachel Wittenauer, Parth D. Shah, Jennifer L. Bacci, Andy Stergachis
Citation: Health Affairs Scholar, 2(4)
Date: 04/2024
Type: Document
view details
Classifies census tracts as pharmacy deserts or non-pharmacy deserts. Compares pharmacy desert and non-pharmacy desert areas by various social determinants of health and pharmacy characteristics including rurality. See the supplemental materials for state-by-state and rural/urban comparisons.
Author(s): Rachel Wittenauer, Parth D. Shah, Jennifer L. Bacci, Andy Stergachis
Citation: Health Affairs Scholar, 2(4)
Date: 04/2024
Type: Document
view details
Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023
Reports on COVID-19 bivalent vaccine doses administered by pharmacies participating in the Federal Retail Pharmacy Program (FRPP) from September 1, 2022–September 30, 2023. Includes data on doses administered in urban and rural settings and discusses urban compared to rural contributions of FRPP pharmacies.
Author(s): Roua El Kalach, Nkenge Jones-Jack, Mattie A. Elam, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(13), 286-290
Date: 04/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on COVID-19 bivalent vaccine doses administered by pharmacies participating in the Federal Retail Pharmacy Program (FRPP) from September 1, 2022–September 30, 2023. Includes data on doses administered in urban and rural settings and discusses urban compared to rural contributions of FRPP pharmacies.
Author(s): Roua El Kalach, Nkenge Jones-Jack, Mattie A. Elam, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 73(13), 286-290
Date: 04/2024
Type: Document
Sponsoring organization: Centers for Disease Control and Prevention
view details
Home Cooked: A 50-Year History of Meth in America - Ep. 2: Made in the U.S.A.
Podcast series presents a discussion on the history of the use, production, and proliferation of methamphetamine in the U.S. Episode 2 discusses the history of legal methamphetamine production and use in the 1930s and follows the drug's production and distribution post-criminalization.
Date: 03/2024
Type: Audio
Sponsoring organizations: Rural Assembly, The Daily Yonder
view details
Podcast series presents a discussion on the history of the use, production, and proliferation of methamphetamine in the U.S. Episode 2 discusses the history of legal methamphetamine production and use in the 1930s and follows the drug's production and distribution post-criminalization.
Date: 03/2024
Type: Audio
Sponsoring organizations: Rural Assembly, The Daily Yonder
view details
Opioid Utilization Dashboard
Interactive map details Medicare beneficiaries using opioids, medications for opioid use disorder (MOUD), and potentially dangerous combinations of other drugs with opioids by state with county-level data.
Date: 03/2024
Type: Map/Mapping System
Sponsoring organization: Quality Improvement Organization Program
view details
Interactive map details Medicare beneficiaries using opioids, medications for opioid use disorder (MOUD), and potentially dangerous combinations of other drugs with opioids by state with county-level data.
Date: 03/2024
Type: Map/Mapping System
Sponsoring organization: Quality Improvement Organization Program
view details
The 340B Drug Pricing Program: A Small Part of the Prescription Drug Market, Delivering Large Benefits to Patients and Communities
Analyzes impacts of the 340B Drug Pricing Program on access, hospital finance, drug companies, and public expenditures. Discusses how the 340B program is shaped by legislation, policy, finance, prescribing patterns, and market influences. Highlights rural and underserved communities throughout.
Date: 03/2024
Type: Document
Sponsoring organization: American Hospital Association
view details
Analyzes impacts of the 340B Drug Pricing Program on access, hospital finance, drug companies, and public expenditures. Discusses how the 340B program is shaped by legislation, policy, finance, prescribing patterns, and market influences. Highlights rural and underserved communities throughout.
Date: 03/2024
Type: Document
Sponsoring organization: American Hospital Association
view details
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Issue brief on prescriptions for generic drugs filled by Medicare Part D enrollees using 2022 Part D prescription drug event (PDE) data. Covers commonly used prescription drugs, costs, and conditions treated, and includes data breakdowns by plan type, race and ethnicity, and level of rurality throughout. Discusses formulary design to improve access by promoting affordability and reducing confusion among enrollees.
Author(s): Yevgeniy Feyman, Bisma Sayed, Kenneth Finegold, et al.
Date: 03/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Inflation Reduction Act Research Series: Projected Impacts for Rural Medicare Enrollees
Provides an overview of how the Inflation Reduction Act (IRA) is intended to improve prescription drug affordability for Medicare enrollees. Describes Medicare enrollment in rural areas and rural residents' health status and access to care. Outlines the projected impact of drug-related IRA provisions for rural Medicare beneficiaries, including the expansion of financial assistance through the low-income subsidy program, out-of-pocket spending caps for insulin, changes in Part D benefit design, and more.
Date: 03/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Provides an overview of how the Inflation Reduction Act (IRA) is intended to improve prescription drug affordability for Medicare enrollees. Describes Medicare enrollment in rural areas and rural residents' health status and access to care. Outlines the projected impact of drug-related IRA provisions for rural Medicare beneficiaries, including the expansion of financial assistance through the low-income subsidy program, out-of-pocket spending caps for insulin, changes in Part D benefit design, and more.
Date: 03/2024
Type: Document
Sponsoring organization: HHS Office of the Assistant Secretary for Planning and Evaluation
view details
Telemedicine vs Telephone Consultations and Medication Prescribing Errors Among Referring Physicians: A Cluster Randomized Crossover Trial
Compared 696 acutely ill children in 15 community and rural California emergency departments receiving telephone or video consultations to determine differences in physician-related medication errors. Discusses the impact of telehealth on healthcare quality and remote acute care.
Author(s): James P. Marcin, Monica K. Lieng, Jamie Mouzoon, et al.
Citation: JAMA Network Open, 7(2)
Date: 02/2024
Type: Document
view details
Compared 696 acutely ill children in 15 community and rural California emergency departments receiving telephone or video consultations to determine differences in physician-related medication errors. Discusses the impact of telehealth on healthcare quality and remote acute care.
Author(s): James P. Marcin, Monica K. Lieng, Jamie Mouzoon, et al.
Citation: JAMA Network Open, 7(2)
Date: 02/2024
Type: Document
view details
Hearing on Examining Chronic Drug Shortages in the United States
Congressional hearing in the U.S. House of Representatives Ways & Means Committee discussing pharmaceutical drug shortages. Discusses cancer care, healthcare quality, the 340B program, supply and demand, reimbursement, and other policy measures. Witnesses include Dr. Stephen Schleicher discussing rural concerns. Captions available in video player.
Additional links: Dr. Stephen Schleicher Testimony
Date: 02/2024
Type: Video/Multimedia
Sponsoring organization: House Ways and Means Committee
view details
Congressional hearing in the U.S. House of Representatives Ways & Means Committee discussing pharmaceutical drug shortages. Discusses cancer care, healthcare quality, the 340B program, supply and demand, reimbursement, and other policy measures. Witnesses include Dr. Stephen Schleicher discussing rural concerns. Captions available in video player.
Additional links: Dr. Stephen Schleicher Testimony
Date: 02/2024
Type: Video/Multimedia
Sponsoring organization: House Ways and Means Committee
view details